AEON Stock Analysis: Buy, Sell, or Hold?
AEON - AEON Biopharma, Inc.
$1.17
0.01 (0.86%)
▲
5d:
-2.5%
30d:
+5.41%
90d:
+37.65%
BUY
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Mar 23, 2026
Get Alerted When AEON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AEON shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: AEON shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: AEON is currently trading at $1.17, which is considered fair relative to its 30-day fair value range of $1.07 to $1.21.
Technical Outlook: Technically, AEON is in a uptrend. Immediate support is located at $1.09, while resistance sits at $1.40.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.20 (+515.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AEON is in a uptrend. Immediate support is located at $1.09, while resistance sits at $1.40.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.20 (+515.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.07 -
$1.21
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 515.4% below Wall St target ($7.20)
Fair Price Analysis
30-Day Fair Range
$1.07 -
$1.21
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.10
Resistance Level
$1.40
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
1.16
Wall Street Target
$7.20
(+515.4%)
Last updated: February 03, 2026 6:42 PM ET
Data refreshes hourly during market hours. Next update: 7:42 PM
Data refreshes hourly during market hours. Next update: 7:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEON showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 56 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 65 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 53 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
